The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world treatment utilization patterns, discontinuation and healthcare resource utilization of first-line (1L) bruton tyrosine kinase inhibitor (BTKi) therapy in chronic lymphocytic leukemia (CLL): Age-related disparity.
 
Keri Yang
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Swetha Challagulla
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Po-Ya Chuang
No Relationships to Disclose
 
Wesley Furnback
Consulting or Advisory Role - Real Chemistry
Research Funding - Real Chemistry
 
Sikander Ailawadhi
Consulting or Advisory Role - Amgen (Inst); Beigene; BMS (Inst); Cellectar (Inst); GlaxoSmithKline; Janssen (Inst); Pharmacyclics (Inst); Regeneron; Sanofi; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Ascentage Pharma (Inst); BMS (Inst); Cellectar (Inst); GlaxoSmithKline (Inst); Janssen Biotech (Inst); Pharmacyclics (Inst); Sanofi (Inst)